BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 23855266)

  • 1. Antitumor activity of 2-hydroxycinnamaldehyde for human colon cancer cells through suppression of β-catenin signaling.
    Lee MA; Park HJ; Chung HJ; Kim WK; Lee SK
    J Nat Prod; 2013 Jul; 76(7):1278-84. PubMed ID: 23855266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway.
    Shan BE; Wang MX; Li RQ
    Cancer Invest; 2009 Jul; 27(6):604-12. PubMed ID: 19440933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wnt/β-catenin signaling mediates the antitumor activity of magnolol in colorectal cancer cells.
    Kang YJ; Park HJ; Chung HJ; Min HY; Park EJ; Lee MA; Shin Y; Lee SK
    Mol Pharmacol; 2012 Aug; 82(2):168-77. PubMed ID: 22550094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical evaluation of destruxin B as a novel Wnt signaling target suppressing proliferation and metastasis of colorectal cancer using non-invasive bioluminescence imaging.
    Yeh CT; Rao YK; Ye M; Wu WS; Chang TC; Wang LS; Wu CH; Wu AT; Tzeng YM
    Toxicol Appl Pharmacol; 2012 May; 261(1):31-41. PubMed ID: 22465936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Periplocin extracted from cortex periplocae induces apoptosis of SW480 cells through inhibiting the Wnt/beta-catenin signaling pathway].
    Du YY; Liu X; Shan BE
    Ai Zheng; 2009 May; 28(5):456-60. PubMed ID: 19624870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celecoxib inhibits the expression of survivin via the suppression of promoter activity in human colon cancer cells.
    Sakoguchi-Okada N; Takahashi-Yanaga F; Fukada K; Shiraishi F; Taba Y; Miwa Y; Morimoto S; Iida M; Sasaguri T
    Biochem Pharmacol; 2007 May; 73(9):1318-29. PubMed ID: 17270149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DIF-1 inhibits the Wnt/β-catenin signaling pathway by inhibiting TCF7L2 expression in colon cancer cell lines.
    Jingushi K; Takahashi-Yanaga F; Yoshihara T; Shiraishi F; Watanabe Y; Hirata M; Morimoto S; Sasaguri T
    Biochem Pharmacol; 2012 Jan; 83(1):47-56. PubMed ID: 22005519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caffeic acid phenethyl ester induces growth arrest and apoptosis of colon cancer cells via the beta-catenin/T-cell factor signaling.
    Xiang D; Wang D; He Y; Xie J; Zhong Z; Li Z; Xie J
    Anticancer Drugs; 2006 Aug; 17(7):753-62. PubMed ID: 16926625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. γ-Tocotrienol inhibits cell viability through suppression of β-catenin/Tcf signaling in human colon carcinoma HT-29 cells.
    Xu W; Du M; Zhao Y; Wang Q; Sun W; Chen B
    J Nutr Biochem; 2012 Jul; 23(7):800-7. PubMed ID: 21852086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer activity of Panax notoginseng extract 20(S)-25-OCH3-PPD: Targetting beta-catenin signalling.
    Bi X; Zhao Y; Fang W; Yang W
    Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1074-8. PubMed ID: 19413587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2,3,6-Trisubstituted quinoxaline derivative, a small molecule inhibitor of the Wnt/beta-catenin signaling pathway, suppresses cell proliferation and enhances radiosensitivity in A549/Wnt2 cells.
    Lee SB; Gong YD; Park YI; Dong MS
    Biochem Biophys Res Commun; 2013 Feb; 431(4):746-52. PubMed ID: 23348226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mastermind-like 1 Is a specific coactivator of beta-catenin transcription activation and is essential for colon carcinoma cell survival.
    Alves-Guerra MC; Ronchini C; Capobianco AJ
    Cancer Res; 2007 Sep; 67(18):8690-8. PubMed ID: 17875709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ganodermanontriol, a lanostanoid triterpene from Ganoderma lucidum, suppresses growth of colon cancer cells through ß-catenin signaling.
    Jedinak A; Thyagarajan-Sahu A; Jiang J; Sliva D
    Int J Oncol; 2011 Mar; 38(3):761-7. PubMed ID: 21225227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periplocin from Cortex periplocae inhibits cell growth and down-regulates survivin and c-myc expression in colon cancer in vitro and in vivo via beta-catenin/TCF signaling.
    Zhao L; Shan B; Du Y; Wang M; Liu L; Ren FZ
    Oncol Rep; 2010 Aug; 24(2):375-83. PubMed ID: 20596624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tussilagone suppresses colon cancer cell proliferation by promoting the degradation of β-catenin.
    Li H; Lee HJ; Ahn YH; Kwon HJ; Jang CY; Kim WY; Ryu JH
    Biochem Biophys Res Commun; 2014 Jan; 443(1):132-7. PubMed ID: 24269588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling.
    Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H
    Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Berberine inhibits the proliferation of colon cancer cells by inactivating Wnt/β-catenin signaling.
    Wu K; Yang Q; Mu Y; Zhou L; Liu Y; Zhou Q; He B
    Int J Oncol; 2012 Jul; 41(1):292-8. PubMed ID: 22469784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based discovery of a novel inhibitor targeting the β-catenin/Tcf4 interaction.
    Tian W; Han X; Yan M; Xu Y; Duggineni S; Lin N; Luo G; Li YM; Han X; Huang Z; An J
    Biochemistry; 2012 Jan; 51(2):724-31. PubMed ID: 22224445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusion of the BCL9 HD2 domain to E1A increases the cytopathic effect of an oncolytic adenovirus that targets colon cancer cells.
    Fuerer C; Homicsko K; Lukashev AN; Pittet AL; Iggo RD
    BMC Cancer; 2006 Oct; 6():236. PubMed ID: 17020613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation-inducing factor-3 inhibits intestinal tumor growth in vitro and in vivo.
    Kubokura N; Takahashi-Yanaga F; Arioka M; Yoshihara T; Igawa K; Tomooka K; Morimoto S; Nakatsu Y; Tsuzuki T; Nakabeppu Y; Matsumoto T; Kitazono T; Sasaguri T
    J Pharmacol Sci; 2015 Apr; 127(4):446-55. PubMed ID: 25913757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.